World COVID-19 Vaccine Production Accelerates as China Licenses Own Doses Overseas
With the G7 group urged by civil society organizations to share COVID-19 vaccine manufacturing technology and provide financial support to the COVID-19 Vaccines Global Access initiative, China is issuing more licenses to its global partners to locally produce Chinese-developed vaccines with at least nine countries across four continents launching production lines for domestic manufacturing, according to calculations. Experts said it will be further scaled up upon the WHO’s approval for more vaccine candidates.